The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.
about
Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potentialEndoglin expression in metastatic breast cancer cells enhances their invasive phenotypeAnti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continuesModulation of CD44 Activity by A6-PeptideIdentification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.Molecular mediators of angiogenesis.RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosisFibrin turnover in lung inflammation and neoplasia.Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in gliomaIn vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancerThe NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesionQuantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cellsRegulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic systemRegulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.How will lung cancer be treated in the future?Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patientsRNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasivenessRegulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapyEnzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer modelWhat is New on Thyroid Cancer BiomarkersA peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin.The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator systemMatrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.
P2860
Q24293732-18BA9FBB-DE45-4516-8112-F221B4EFD935Q24307831-D90AE73F-D138-42E1-8090-141576EFDDD9Q24620190-34CD7640-DF26-4514-9047-36F8D886752DQ26776389-E3648D09-E84A-4BA6-9568-88BE6C1C776EQ28085166-7B593BCA-A9C9-4FC6-8067-8EF2A1D48705Q30354565-262E67D4-CD18-4812-94E8-C99E9F454CD4Q31506532-8DA53E87-E790-4A67-8459-3F1C25620F6EQ33639474-92102FCF-4D14-4390-B53D-A5A9BAEE33C7Q33713013-16024ABC-FA96-45CD-B093-D15867E4500DQ33783271-26CB38F7-BBCC-4A88-B43A-B2930B0E61D8Q34141236-80E88625-C91D-4C4C-AB7B-2CBF56E6E27DQ34293732-EAA17348-5045-499A-B07F-3679E367B94EQ34606581-890A0B95-4FC1-4FD6-A753-143CC333149BQ34987834-B694F7F4-5879-4A4F-8411-B0B0FD1846DDQ34997475-7172D9DC-25D1-4035-BD99-A73AFA2E6126Q35069222-9139ED81-2A0A-468A-A1C7-9B294D6A5C75Q35107356-270C9E7D-0E2E-4602-B620-7466CABBB979Q35693267-C13174C3-718D-40A8-B8CC-E555D935DB23Q35850241-EFFBEB71-869B-4A27-A882-49DF0904ECDFQ35950247-498FBB10-C761-4AA4-B51D-455B7CA3C2ABQ36198192-B7527479-C45D-4205-8D82-B3F47660E6C9Q36429550-F2628965-5494-4588-9DCD-A10ED07CCE8EQ36647843-A4236490-2D17-47F2-B943-CEA491AB05D1Q36676608-C909D6F5-0759-4259-A7C8-50EEB0E224B4Q36982983-F2BB7222-B1E0-44CB-9D3F-249F28E0C9C9Q36986513-D465D23C-551C-4EBB-B264-E2DA565654B8Q36997627-D54AD4CC-78FC-4C94-B377-FB6EA17D29A6Q37078275-7999130A-5A68-471D-AA92-AB248740195BQ37078600-9AE49454-F6A0-44EF-BBF3-3A7E8097C24CQ37098900-6B631E04-A3FB-4E3C-9435-4DADFC74013BQ37146678-E93B45C8-F4DC-442D-AE57-4FA8871C1CE4Q37207279-527147F6-A003-4CAC-816A-97C3A78561FCQ37230030-6772AD5C-B427-418A-8B4D-A4F7D1795FD8Q37286882-BDEF3599-574E-4AB8-B61C-B861A3C4B0C0Q37310583-9486F1E2-E09D-4D82-AEF1-D1D75326A034Q37336713-5A2C28A1-9640-465F-97DD-EF8969CFEA9FQ37364683-785C6AEA-E259-4F4C-8A47-B9F45EEBFBBCQ37419308-DB225416-F0BF-49AD-B83C-45A19D947B82Q37646911-7A47BA9E-14B6-466B-9D81-8F839FC0FBCBQ37967510-9E517EC2-4303-4E2D-A527-EB3FD1876CF9
P2860
The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@ast
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@en
type
label
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@ast
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@en
prefLabel
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@ast
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@en
P2093
P356
P1433
P1476
The urokinase plasminogen acti ...... r angiogenesis and metastasis.
@en
P2093
P2888
P356
10.1023/A:1009095825561
P577
1999-01-01T00:00:00Z
P6179
1023219569